A Study at the Center of the Abortion Pill Battle Was Just Retracted
A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits. ..
A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits. ..
Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria. ..
Biotech company Contraline has safely implanted a sperm-blocking hydrogel in 23 men. It’s designed to be a fully reversible vasectomy. ..
As researchers try to make sense of “open-label” placebos—fake drugs that proudly announce their fakeness—the mysterious effect is starting to show ..
It’s still early days for a novel form of gene therapy called base editing, but this small study in people with extremely high cholesterol shows striking ..
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. ..
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs. ..
The latest vaccines are designed to target XBB.1.5, the dominant variant throughout much of 2023—until now. ..
A new study shows that semaglutide reduces heart failure symptoms like fatigue and swelling by bringing down body weight. ..
Current treatments for depression after giving birth are either slow to work or hard to get. The FDA is considering a new tablet that relieves symptoms ..